IL117194A0 - Amplifying sequences vectors comprising them and their uses in compositions for the expression of nucleotide sequences and pharmaceutical compositions containing them - Google Patents

Amplifying sequences vectors comprising them and their uses in compositions for the expression of nucleotide sequences and pharmaceutical compositions containing them

Info

Publication number
IL117194A0
IL117194A0 IL11719496A IL11719496A IL117194A0 IL 117194 A0 IL117194 A0 IL 117194A0 IL 11719496 A IL11719496 A IL 11719496A IL 11719496 A IL11719496 A IL 11719496A IL 117194 A0 IL117194 A0 IL 117194A0
Authority
IL
Israel
Prior art keywords
sequences
expression
sequence
amplifying
vectors
Prior art date
Application number
IL11719496A
Other languages
English (en)
Original Assignee
Pasteur Institut
Univ Paris Vii
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Univ Paris Vii filed Critical Pasteur Institut
Publication of IL117194A0 publication Critical patent/IL117194A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL11719496A 1995-02-20 1996-02-20 Amplifying sequences vectors comprising them and their uses in compositions for the expression of nucleotide sequences and pharmaceutical compositions containing them IL117194A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9501937A FR2730735B1 (fr) 1995-02-20 1995-02-20 Sequences amplificatrices, vecteurs portant ces sequences et leurs utilisations dans des compositions pour l'expression de sequences nucleotidiques dans des cellules transfectees, applications therapeutiques et vaccinales

Publications (1)

Publication Number Publication Date
IL117194A0 true IL117194A0 (en) 1996-06-18

Family

ID=9476320

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11719496A IL117194A0 (en) 1995-02-20 1996-02-20 Amplifying sequences vectors comprising them and their uses in compositions for the expression of nucleotide sequences and pharmaceutical compositions containing them

Country Status (15)

Country Link
US (2) US5914395A (pt)
EP (1) EP0811071B1 (pt)
JP (1) JPH11500905A (pt)
AT (1) ATE212060T1 (pt)
AU (1) AU710697B2 (pt)
CA (1) CA2211435A1 (pt)
DE (1) DE69618574T2 (pt)
DK (1) DK0811071T3 (pt)
ES (1) ES2168459T3 (pt)
FR (1) FR2730735B1 (pt)
IL (1) IL117194A0 (pt)
MX (1) MX9706290A (pt)
PT (1) PT811071E (pt)
WO (1) WO1996026284A1 (pt)
ZA (1) ZA961349B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2246664A1 (en) * 1998-10-02 2000-04-02 Universite Paris 7 Vascular specific regulatory elements contained in the desmin 5' flanking region
WO2005014642A2 (en) 2003-07-21 2005-02-17 Transgene S.A. Novel multifunctional cytokines
AU2011230619C1 (en) 2010-03-25 2016-06-23 Oregon Health & Science University CMV glycoproteins and recombinant vectors
LT2691530T (lt) 2011-06-10 2018-08-10 Oregon Health & Science University Cmv glikoproteinai ir rekombinantiniai vektoriai
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
WO2014066443A1 (en) 2012-10-23 2014-05-01 Emory University Gm-csf and il-4 conjugates, compositions, and methods related thereto
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3800261A1 (en) 2014-01-21 2021-04-07 Vrije Universiteit Brussel Muscle-specific nucleic acid regulatory elements and methods and use thereof
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3723075A1 (de) * 1987-07-11 1989-01-19 Boehringer Mannheim Gmbh Eukaryotische expressionsvektoren mit multimeren enhancer-subelementen, verfahren zu ihrer herstellung und verwendung
US5503980A (en) * 1992-11-06 1996-04-02 Trustees Of Boston University Positional sequencing by hybridization

Also Published As

Publication number Publication date
EP0811071B1 (fr) 2002-01-16
MX9706290A (es) 1998-02-28
EP0811071A1 (fr) 1997-12-10
CA2211435A1 (fr) 1996-08-29
FR2730735A1 (fr) 1996-08-23
DE69618574D1 (de) 2002-02-21
DK0811071T3 (da) 2002-04-29
DE69618574T2 (de) 2002-08-14
JPH11500905A (ja) 1999-01-26
ES2168459T3 (es) 2002-06-16
WO1996026284A1 (fr) 1996-08-29
AU4835696A (en) 1996-09-11
ZA961349B (en) 1996-09-05
AU710697B2 (en) 1999-09-30
FR2730735B1 (fr) 1997-05-09
US5914395A (en) 1999-06-22
ATE212060T1 (de) 2002-02-15
US6201115B1 (en) 2001-03-13
PT811071E (pt) 2002-07-31

Similar Documents

Publication Publication Date Title
HUP0204199A2 (hu) Transzport vektorok
IL117194A0 (en) Amplifying sequences vectors comprising them and their uses in compositions for the expression of nucleotide sequences and pharmaceutical compositions containing them
AU8067698A (en) Chimeric vectors comprising a phage packaging site and a portion derived from a genome of a eukaryotic virus
AU2795292A (en) Synthetic dna sequence having enhanced insecticidal activity in maize
AU2003264419A1 (en) Kdr peptides and vaccines containing the same
AU6871398A (en) Method for enhancing expression of a foreign or endogenous gene product in pla nts
AU7189394A (en) Retroviral vector for the transfer and expression of genes for therapeutical purposes in eucaryotic cells
BG101355A (en) Viral material and nucleotide fragments related to multiplesclerosis, for the diagnostics, prophylaxy and treatment of thisdisease
WO2003093417A3 (en) Lentiviral vector particles resistant to complement inactivation
AU6724794A (en) GRB3-3 gene, its variants and their uses
DE69524971T2 (de) Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen
AU5776799A (en) Modified hcv peptide vaccines
WO2000012741A3 (fr) Systeme d'expression inductible
DE60028217D1 (de) Zyklische depsipeptid-synthasen, deren gene und system zur massenproduktion von zyklischen depsipeptiden
GB9416536D0 (en) Orphan receptor
WO2002068662A8 (en) Plasmid originated from bifidobacterium, recombinant expression vector using the plasmid and transformation method
HUP0104598A1 (hu) Hepatocita-eredetű növekedési faktorból (HGF) és makrofágstimuláló proteinből (MSP) származó rekombináns proteinek
RU94030484A (ru) Плазмида, вектор, микроорганизм, лактобациллы, применение плазмиды и вектора
ES2161130A1 (es) Dna recombinante derivado del virus de la sharka y vector de expresion de proteinas heterologas basado en dicho dna recombinante.
CA2419038A1 (en) Nucleic acid and protein increasing expression levels under salt stress
WO2000053789A3 (de) Retrovirale expressionsvektoren auf der basis von herv-ltr-sequenzen